97934574 - EXO-STAMP

Information

• Trademark
• 97934574

• Source

• Serial Number

  97934574

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 12, 2023
  a year ago

• Transaction Date

  January 10, 2024
  10 months ago

• Status Date

  January 10, 2024
  10 months ago

• Location Date

  January 10, 2024
  10 months ago

• Status Code

  653

• Current Location

  TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  ANGOTTI, SALVATORE JOH

• Attorney Name

  Janice Housey

  Law Office Assigned Location Code

  L80

• Owners

  • ILIAS BIOLOGICS INC

Case File Statements

• DM0000: The mark consists of "Exo" followed by a dash then "STAMP".
• GS0051: Biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; biochemical preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceuticals featuring drug delivery system, namely, Pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; preparations for intracellular drug delivery, namely, drug delivery agents in the form of capsules, tablets, pills, powders, liquids, suspensions, injection, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations; pharmaceuticals for the treatment of immune system disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of cellular diseases; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; protein preparations, namely, protein supplements; biotechnological preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; reagents for medical use; pharmaceuticals for human purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; biochemical pharmaceuticals for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease; biological tissue cultures for medical purposes; diagnostic reagents for medical use; pharmaceuticals for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary disease
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Biological preparations, other than for medical or veterinary purposes; biological preparation for use in experiments other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; biological preparations for use in experiments containing exosomes carrying the desired protein, other than for medical or veterinary use; biochemical preparations for gene recombination for scientific or laboratory purposes; biological tissue cultures, other than for medical or veterinary purposes; cells for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for use in biological or genetic engineering for scientific or research use and medical laboratory use; reagents for scientific or medical research use; biological preparations for use in biotechnology industry and science, other than for medical purpose; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; reagents for medical research; biological preparation containing exosomes for use in manufacture of cosmetics; protein for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; chemical additives for use in the manufacture of cosmetics; proteins for the food industry
• GS0421: Drug discovery services using cells; research on the subject of pharmaceuticals; development of pharmaceutical preparations; biomedical research services; scientific research relating to biology; industrial research in the fields of biology; scientific research consultation and providing scientific information in the fields of biology; laboratory research in the field of biology; biological research and analysis; biological research services; product development of devices for biological chemicals analysis; product development in the field of biologics; research of biologics, namely, scientific study and research in the field of biologics; research and development of technology for biotechnology; consultancy in the field of biotechnology; biotechnology research; providing scientific research information relating to scientific analysis of the genetic information via online networks; biological information check, namely, genetic testing for scientific research purposes

Case File Event Statements

• 1/10/2024 - 10 months ago

  7 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 1/10/2024 - 10 months ago

  6 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 1/10/2024 - 10 months ago

  5 - SUSPENSION LETTER WRITTEN Type: CNSL

• 12/13/2023 - 11 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/13/2023 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 6/12/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/16/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP